Annual SG&A
$13.00 M
-$2.93 M-18.41%
31 December 2023
Summary:
NexImmune annual selling, general & administrative expenses is currently $13.00 million, with the most recent change of -$2.93 million (-18.41%) on 31 December 2023. During the last 3 years, it has risen by +$2.99 million (+29.84%). NEXI annual SG&A is now -18.41% below its all-time high of $15.93 million, reached on 31 December 2022.NEXI Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$2.08 M
+$69.10 K+3.43%
30 June 2024
Summary:
NexImmune quarterly selling, general & administrative expenses is currently $2.08 million, with the most recent change of +$69.10 thousand (+3.43%) on 30 June 2024. Over the past year, it has dropped by -$1.91 million (-47.80%). NEXI quarterly SG&A is now -54.77% below its all-time high of $4.60 million, reached on 31 March 2022.NEXI Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$893.50 M
-$20.62 M-2.36%
30 June 2024
Summary:
NexImmune TTM selling, general & administrative expenses is currently -$893.50 million, with the most recent change of -$20.62 million (-2.36%) on 30 June 2024. Over the past year, it has dropped by -$907.62 million (-6429.15%). NEXI TTM SG&A is now -1772.53% below its all-time high of $16.40 million, reached on 30 June 2022.NEXI TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NEXI Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -18.4% | -47.8% | -6429.1% |
| 3 y3 years | +29.8% | -49.9% | -6112.3% |
| 5 y5 years | +147.9% | - | - |
NEXI Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -18.4% | +29.8% | -54.8% | +3.4% | -139.7% | at low |
| 5 y | 5 years | -18.4% | +147.9% | -54.8% | +41.8% | -1772.5% | at low |
| alltime | all time | -18.4% | +147.9% | -54.8% | +41.8% | -1772.5% | at low |
NexImmune Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | $2.08 M(+3.4%) | $10.49 M(-7.3%) |
| Mar 2024 | - | $2.01 M(-16.3%) | $11.31 M(-13.0%) |
| Dec 2023 | $13.00 M(-18.4%) | $2.41 M(-39.7%) | $13.00 M(-7.9%) |
| Sept 2023 | - | $3.99 M(+37.4%) | $14.12 M(+2.0%) |
| June 2023 | - | $2.90 M(-21.5%) | $13.85 M(-7.9%) |
| Mar 2023 | - | $3.70 M(+5.1%) | $15.03 M(-5.7%) |
| Dec 2022 | $15.93 M(+0.9%) | $3.52 M(-5.3%) | $15.93 M(-0.1%) |
| Sept 2022 | - | $3.72 M(-9.0%) | $15.96 M(-2.7%) |
| June 2022 | - | $4.09 M(-11.2%) | $16.40 M(+0.3%) |
| Mar 2022 | - | $4.60 M(+29.9%) | $16.35 M(+3.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $15.80 M(+57.8%) | $3.54 M(-14.8%) | $15.80 M(+6.3%) |
| Sept 2021 | - | $4.16 M(+3.0%) | $14.86 M(+10.5%) |
| June 2021 | - | $4.04 M(-0.5%) | $13.45 M(+12.3%) |
| Mar 2021 | - | $4.06 M(+55.7%) | $11.98 M(+19.7%) |
| Dec 2020 | $10.01 M(+75.2%) | $2.61 M(-5.3%) | $10.01 M(+12.8%) |
| Sept 2020 | - | $2.75 M(+7.3%) | $8.87 M(+45.0%) |
| June 2020 | - | $2.57 M(+22.8%) | $6.12 M(+72.1%) |
| Mar 2020 | - | $2.09 M(+42.2%) | $3.56 M(+142.2%) |
| Dec 2019 | $5.71 M(+9.0%) | $1.47 M | $1.47 M |
| Dec 2018 | $5.24 M | - | - |
FAQ
- What is NexImmune annual selling, general & administrative expenses?
- What is the all time high annual SG&A for NexImmune?
- What is NexImmune annual SG&A year-on-year change?
- What is NexImmune quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for NexImmune?
- What is NexImmune quarterly SG&A year-on-year change?
- What is NexImmune TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for NexImmune?
- What is NexImmune TTM SG&A year-on-year change?
What is NexImmune annual selling, general & administrative expenses?
The current annual SG&A of NEXI is $13.00 M
What is the all time high annual SG&A for NexImmune?
NexImmune all-time high annual selling, general & administrative expenses is $15.93 M
What is NexImmune annual SG&A year-on-year change?
Over the past year, NEXI annual selling, general & administrative expenses has changed by -$2.93 M (-18.41%)
What is NexImmune quarterly selling, general & administrative expenses?
The current quarterly SG&A of NEXI is $2.08 M
What is the all time high quarterly SG&A for NexImmune?
NexImmune all-time high quarterly selling, general & administrative expenses is $4.60 M
What is NexImmune quarterly SG&A year-on-year change?
Over the past year, NEXI quarterly selling, general & administrative expenses has changed by -$1.91 M (-47.80%)
What is NexImmune TTM selling, general & administrative expenses?
The current TTM SG&A of NEXI is -$893.50 M
What is the all time high TTM SG&A for NexImmune?
NexImmune all-time high TTM selling, general & administrative expenses is $16.40 M
What is NexImmune TTM SG&A year-on-year change?
Over the past year, NEXI TTM selling, general & administrative expenses has changed by -$907.62 M (-6429.15%)